NASDAQ:TNYA | Free Cash Flow | Tenaya Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$19.23M$11,000.00-$19.25M
2025-12-31-$13.94M$67,000.00-$14.01M
2025-03-31-$23.11M$383,000.00-$23.5M
2024-12-31-$18.39M$204,000.00-$18.59M
2024-03-31-$28.66M$564,000.00-$29.22M
2023-12-31-$21.92M$394,000.00-$22.32M
2023-03-31-$30.29M$629,000.00-$30.92M
2022-12-31-$22.68M$795,000.00-$23.48M
2022-03-31-$28.76M$8.6M-$37.35M
2021-12-31-$16.35M$12.55M-$28.9M
2021-03-31-$15.79M$4.32M-$20.11M
2020-12-31-$10.4M$8.18M-$18.58M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$68.26M$618,000.00-$68.88M
2024-12-31-$90.5M$1.03M-$91.53M
2023-12-31-$102.07M$1.24M-$103.31M
2022-12-31-$104.42M$20.63M-$125.05M
2021-12-31-$60.81M$25.12M-$85.93M
2020-12-31-$35.45M$9.76M-$45.21M